Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Integra Acquisition Strategy Boosts Q2 Sales, Clouds Organic Growth Rate

This article was originally published in The Gray Sheet

Executive Summary

Integra LifeSciences will continue to pursue potential acquisitions after completing four deals so far this year

You may also be interested in...



Integra Buys IsoTis, Gains Accell Demineralized Bone Matrix In $51 Mil. Deal

Closure of Integra LifeSciences' acquisition of orthobiologics firm IsoTis is conditioned upon 510(k) clearance for IsoTis' Accell line of demineralized bone matrix products, Integra says

Integra Buys IsoTis, Gains Accell Demineralized Bone Matrix In $51 Mil. Deal

Closure of Integra LifeSciences' acquisition of orthobiologics firm IsoTis is conditioned upon 510(k) clearance for IsoTis' Accell line of demineralized bone matrix products, Integra says

Orthopedic News In Brief

Medtronic imager guides spine surgery: Firm launches Synergy Experience StealthStation image guidance system Feb. 14. Integrating Medtronic's navigation and minimally invasive access technologies, the system depicts the spine in multiple planes simultaneously to help surgeons perform complex minimally invasive surgeries without being exposed to dangerous radiation. Medtronic has more than 2,300 StealthStation and intra-operative imaging customers worldwide in the cranial, spine and orthopedic markets...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023851

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel